Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 9Breast Neoplasms 8Lymphoma, Mantle-Cell 7Leukemia, Myeloid, Acute 7Leukemia 7Congenital Abnormalities 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Myeloproliferative Disorders 6Multiple Myeloma 6Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 6Lymphoma, Non-Hodgkin 5Lymphoma, Large B-Cell, Diffuse 5Burkitt Lymphoma 5Waldenstrom Macroglobulinemia 4Myelodysplastic Syndromes 4Lymphoma, Large-Cell, Immunoblastic 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myeloid, Chronic-Phase 4Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Sezary Syndrome 3Mycosis Fungoides 3Melanoma 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Extranodal NK-T-Cell 3Lymphoma 3Lung Neoplasms 3Leukemia, Myeloid, Accelerated Phase 3Hodgkin Disease 3

Interventions

Dexamethasone 14Lenalidomide 13Calcium Dobesilate 7carfilzomib 4dexamethasone acetate 3dexamethasone 21-phosphate 3auricularum 3Melphalan 3Leflunomide 3Curcumin 3isatuximab 2iberdomide 2daratumumab 2Denosumab 2Cyclophosphamide 2Bortezomib 2selinexor 1pomalidomide 1poly ICLC 1piperine 1pembrolizumab 1ixazomib 1ibrutinib 1fludarabine phosphate 1fludarabine 1elotuzumab 1citarinostat 1atezolizumab 1Urination 1Transplantation, Autologous 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Smoldering Multiple Myeloma × In Situ Hybridization, Fluorescence × Clear all
NCT00112827 2025-06-06

Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma

City of Hope Medical Center

Phase 1/2 Completed
54 enrolled 13 charts
Plasma cell

Smoldering Multiple Myeloma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡